Andre Terzic, M.D., Ph.D.

Dr. Terzic is: Marriott Family Professor; Director, Marriott Heart Disease Research Program; and Director, National Institutes of Health Cardiovasology Program at Mayo Clinic, where he was the inaugural Michael & Mary Sue Shannon Director at the Center for Regenerative Medicine and Associate Dean for Research. He chairs the FDA Pharmaceutical Science & Clinical Pharmacology Advisory Committee and is Deputy Chair at the Berlin Institute of Health Scientific Advisory Board. Prior, Dr. Terzic served as President at the American Society for Clinical Pharmacology & Therapeutics. Dr. Terzic was conferred: the American Heart Association Basic Research Prize “for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular disorders;” the Madrid Award for Excellence in Cardiovascular Regenerative Research “for leadership and success in translating stem cell theory into practice;” and the Hellenic Heart Failure Research Society Honorary Fellowship for “contributions to Heart Failure and Cardiovascular Medicine.” He is the recipient of numerous national and international awards. Dr. Terzic trained at University of Paris, Belgrade, and Illinois, followed by fellowships at the French National Institutes of Health, Thomas Jefferson University, and Mayo Clinic.